Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1217.HK Stock Summary
In the News
1217.HK Financial details
Company Rating
Sell
Market Cap
140.82M
Income
16.02M
Revenue
40.83M
Book val./share
0.04
Cash/share
0.02
Dividend
-
Dividend %
-
Employees
21
Optionable
No
Shortable
Yes
Earnings
22 Mar 2024
P/E
24.46
Forward P/E
-
PEG
-1.65
P/S
6.99
P/B
0.25
P/C
0.55
P/FCF
-9.16
Quick Ratio
178.74
Current Ratio
435.2
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-118.52%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-8.97%
Revenue last 5Y
NAN%
Revenue Q/Q
-16.42%
EPS Q/Q
100%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
1%
ROE
1%
ROC
0.01%
Gross Margin
100%
Oper. Margin
29%
Profit Margin
29%
Payout
-
Shs Outstand
12.8B
Shs Float
8.98B
-
-
-
-
Target Price
-
52W Range
0.01-0.011
52W High
-
52W Low
-
RSI
-
Rel Volume
3.08
Avg Volume
4.82M
Volume
14.84M
Perf Week
10%
Perf Month
-
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
0.068
-
-
Volatility
0%, 0%
Prev Close
10%
Price
0.011
Change
10%
1217.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | -0.01 | -0.01 | 0 | 0 | 0 | |
Free cash flow per share | -0.01 | -0.01 | 0 | 0 | 0 | |
Cash per share | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 | |
Book value per share | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | |
Tangible book value per share | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | |
Share holders equity per share | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 230.43M | 153.62M | 128.02M | 128.02M | 128.02M | |
Enterprise value | 43.13M | 141.39M | 113.46M | 116.02M | 121.83M | |
P/E ratio | 22.65 | 6.44 | -12.96 | -3.76 | 22.24 | |
Price to sales ratio | -47.07 | 4.81 | -35.14 | -4.79 | 6.35 | |
POCF ratio | -2.34 | -0.9 | -72.49 | -6.61 | -8.56 | |
PFCF ratio | -2.34 | -0.9 | -72.49 | -6.61 | -8.33 | |
P/B Ratio | 0.34 | 0.22 | 0.2 | 0.21 | 0.23 | |
PTB ratio | 0.34 | 0.22 | 0.2 | 0.21 | 0.23 | |
EV to sales | -8.81 | 4.42 | -31.14 | -4.34 | 6.05 | |
Enterprise value over EBITDA | -1.65 | 5.69 | -12.84 | -3.52 | 18.11 | |
EV to operating cash flow | -0.44 | -0.83 | -64.25 | -5.99 | -8.15 | |
EV to free cash flow | -0.44 | -0.83 | -64.25 | -5.99 | -7.93 | |
Earnings yield | 0.04 | 0.16 | -0.08 | -0.27 | 0.04 | |
Free cash flow yield | -0.43 | -1.11 | -0.01 | -0.15 | -0.12 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 7.17 | -0.49 | 1.65 | 0.36 | -0.92 | |
Current ratio | 1.43K | 32.63 | 313.11 | 285.46 | 435.2 | |
Interest coverage | 0 | 531.49 | -147.68 | -380.16 | 128.91 | |
Income quality | -9.68 | -7.16 | 0.18 | 0.57 | -2.6 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | -1.27 | 0.25 | -1.73 | -0.27 | 0.32 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0.03 | |
Capex to revenue | 0 | 0 | 0 | 0 | -0.02 | |
Capex to depreciation | 0 | 0 | 0 | 0 | -0.45 | |
Stock based compensation to revenue | -0.19 | 0 | -0.09 | 0 | 0 | |
Graham number | 0.03 | 0.05 | 0.03 | 0.05 | 0.02 | |
ROIC | -0.05 | 0.03 | -0.01 | -0.06 | 0.01 | |
Return on tangible assets | 0.01 | 0.03 | -0.02 | -0.06 | 0.01 | |
Graham Net | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | |
Working capital | 386.3M | 384.79M | 376.72M | 342.77M | 334.33M | |
Tangible asset value | 684.26M | 700.26M | 653.75M | 611M | 563.26M | |
Net current asset value | 386.3M | 384.79M | 375.33M | 342.3M | 334.33M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 723K | 3.23M | 3.32M | 1.63M | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 192.08M | 192.08M | 0 | |
Days sales outstanding | 0 | 16.51 | -502.86 | -22.18 | 29.78 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 154.26K | 0 | 0 | |
Receivables turnover | 0 | 22.11 | -0.73 | -16.46 | 12.26 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.01 | 0.03 | -0.02 | -0.06 | 0.01 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0.01 | 0.02 | 0.02 | |
Book value per share | 0 | 0.04 | 0.04 | 0.04 | 0.04 | |
Tangible book value per share | 0 | 0.04 | 0.04 | 0.04 | 0.04 | |
Share holders equity per share | 0 | 0.04 | 0.04 | 0.04 | 0.04 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 128.41M | 128.02M | 128.35M | 128.02M | |
Enterprise value | -9.11M | 121.75M | 121.83M | 124.65M | 124.32M | |
P/E ratio | 0 | 18.12 | 9.03 | 8.99 | 4.48 | |
Price to sales ratio | 0 | 42.08 | 4.51 | 25.03 | 29.88 | |
POCF ratio | 0 | -30.23 | 253 | -47.73 | -23.8 | |
PFCF ratio | 0 | -28.81 | 431.76 | -47.73 | -23.8 | |
P/B Ratio | 0 | 0.23 | 0.23 | 0.23 | 0.22 | |
PTB ratio | 0 | 0.23 | 0.23 | 0.23 | 0.22 | |
EV to sales | 0 | 39.9 | 4.3 | 24.31 | 29.01 | |
Enterprise value over EBITDA | 0 | 17.39K | 29.93 | 32.72 | 15.41 | |
EV to operating cash flow | 0 | -28.66 | 240.78 | -46.35 | -23.12 | |
EV to free cash flow | 0 | -27.31 | 410.91 | -46.35 | -23.12 | |
Earnings yield | 0 | 0.01 | 0.03 | 0.03 | 0.06 | |
Free cash flow yield | 0 | -0.03 | 0 | -0.02 | -0.04 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | -950.86 | -1.52 | -0.97 | -0.46 | |
Current ratio | 319.23 | 435.2 | 435.2 | 42.75K | 42.75K | |
Interest coverage | 0 | 0 | 0 | 0 | 16.44 | |
Income quality | 0 | -2.4 | 0.14 | -0.75 | -0.75 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.42 | 0.04 | 0.26 | 0.31 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0.05 | -0.41 | 0 | 0 | |
Capex to revenue | 0 | -0.07 | -0.01 | 0 | 0 | |
Capex to depreciation | 0 | -0.87 | -0.44 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0.01 | 0.02 | 0.02 | 0.02 | |
ROIC | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Return on tangible assets | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Graham Net | 0 | 0 | 0.01 | 0.02 | 0.02 | |
Working capital | 344.96M | 334.33M | 334.33M | 341.96M | 341.96M | |
Tangible asset value | 613.21M | 563.26M | 563.26M | 570.39M | 570.39M | |
Net current asset value | 344.96M | 334.33M | 334.33M | 341.96M | 341.96M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 822K | 822K | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 5.22 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 17.25 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
1217.HK Frequently Asked Questions
What is China Innovation Investment Limited stock symbol ?
China Innovation Investment Limited is a HK stock and trading under the symbol 1217.HK
What is China Innovation Investment Limited stock quote today ?
China Innovation Investment Limited stock price is $0.011 today.
Is China Innovation Investment Limited stock public?
Yes, China Innovation Investment Limited is a publicly traded company.